Given its role in cell proliferation and tissue repair, KGF and its signaling pathways present potential targets for cancer therapy. Inhibitors of FGFR2b or blocking antibodies against KGF could be explored as therapeutic strategies to prevent KGF-induced tumor growth. However, such approaches would need to be balanced against the beneficial effects of KGF in tissue repair and mucosal protection.
